Accuray touts trigeminal neuralgia CyberKnife study results

This study is important because it reinforces that CyberKnife SRS provides unique benefits in the treatment of TN. Pain management goals were achieved and bothersome complications were rare even though a less invasive approach to delivering radiation was used. Importantly, we used a consistent treatment protocol for each patient that resulted in reproducible outcomes. This should provide confidence to other clinicians that they, too, can achieve similar clinical results,” Dr. Pantaleo Romanelli of Milan, Italy’s Centro Diagnostico Italiano said in a prepared statement. Data from the 138-patient study indicated that pain relief was achieved in 93.5% of patients after a median delay of 3 weeks after treatment with the CyberKnife system, Accuray said. Stable pain control was maintained by 76% of patients three years after the first treatment, with the remainder of patients attaining pain control after a second treatment. A total of 78.9% of patients reported being completely pain and medication-free within six months post-treatment, while 93.5% of patients were able to to decrease pain medication dosage throughout their follow-ups and eventually cease pain medication. Results also indicated that 18.1% of patients developed some sensory disturbance, with 68% experiencing the onset of complications after their second treatment, which Accuray said is a typical side effect following re-irradiation. “The frameless CyberKnife robotic radiosurgery system delivers rad...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Neurological Pain Management Accuray Inc. Source Type: news